HB29 Alabama 2012 Session

Summary

Primary Sponsor

Mike Millican

Republican

Session

Regular Session 2012

Title

Ephedrine, pseudoephedrine, and phenylpropanolamine, State Board of Health required to classify as controlled substances, exemptions, removed from list of precursor chemicals maintained by State Board of Pharmacy, Secs. 20-2-20, 20-2-181 am'd.

Summary

HB29 would make ephedrine, pseudoephedrine, and phenylpropanolamine Schedule III controlled substances to be sold by prescription, with possible exemptions for products designed to prevent meth production, and it updates precursor chemical listings.

What This Bill Does

The State Board of Health would classify these three substances as Schedule III and can exempt products containing them if they are effectively formulated to prevent meth creation. The board could revoke an exemption if the Department of Public Safety notifies that the product no longer prevents meth production, potentially via an emergency rule pending a hearing. The Board of Pharmacy would list these substances as listed precursors and manage additions or deletions to the precursor list by rule, aligning with federal actions within 30 days unless they object.

Who It Affects

• Consumers who purchase products containing ephedrine, pseudoephedrine, or phenylpropanolamine would generally need a prescription, unless a product is exempted by the Board of Health.
• Manufacturers and distributors of products containing these ingredients would may apply for exemptions if their products are formulated to prevent conversion to methamphetamine, and must comply with potential revocation and regulatory rules.

Key Provisions

• Classify ephedrine, pseudoephedrine, and phenylpropanolamine as Schedule III controlled substances under state law.
• Authorize the Board of Health to exempt products containing these ingredients from scheduling if the product is effectively formulated to prevent conversion to methamphetamine or its precursors.
• Authorize the Board of Health to revoke an exemption after notification from the Department of Public Safety that the product no longer effectively prevents conversion to methamphetamine, with an emergency rule permissible pending a hearing.
• Require the State Board of Pharmacy to designate listed precursor chemicals, including these three substances, and to add or delete chemicals by rule following federal criteria, with implementation timelines tied to federal actions.
• Effective date set for the first day of the third month after passage.

AI-generated summary using openai/gpt-5-nano on Feb 24, 2026. May contain errors — refer to the official bill text for accuracy.

Subjects

Controlled Substances